These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38463290)
1. Impact of Protein Phosphatase Expressions on the Prognosis of Hepatocellular Carcinoma Patients. Mestareehi A; Abu-Farsakh N ACS Omega; 2024 Mar; 9(9):10299-10331. PubMed ID: 38463290 [TBL] [Abstract][Full Text] [Related]
2. Global Gene Expression Profiling and Bioinformatics Analysis Reveal Downregulated Biomarkers as Potential Indicators for Hepatocellular Carcinoma. Mestareehi A ACS Omega; 2024 Jun; 9(24):26075-26096. PubMed ID: 38911766 [No Abstract] [Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
4. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis. Sun Q; Liu P; Long B; Zhu Y; Liu T Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939 [TBL] [Abstract][Full Text] [Related]
5. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma. Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y PeerJ; 2021; 9():e11342. PubMed ID: 33987018 [TBL] [Abstract][Full Text] [Related]
6. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
7. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876 [TBL] [Abstract][Full Text] [Related]
8. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405 [TBL] [Abstract][Full Text] [Related]
9. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas. Liu D; Li J; Li N; Lu M; Wen S; Zhan X EPMA J; 2020 Sep; 11(3):419-467. PubMed ID: 32849927 [TBL] [Abstract][Full Text] [Related]
10. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618 [TBL] [Abstract][Full Text] [Related]
11. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods. Li Z; Lin Y; Cheng B; Zhang Q; Cai Y Front Genet; 2021; 12():571231. PubMed ID: 33767726 [TBL] [Abstract][Full Text] [Related]
12. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
14. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma]. Yu Y; Cheng J; Mei CZ; Dai YZ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255 [TBL] [Abstract][Full Text] [Related]
15. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
16. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing. Zheng Y; Long J; Wu L; Zhang H; Li L; Zheng Y; Wang A; Lin J; Yang X; Sang X; Hu K; Pan J; Zhao H Oncotarget; 2017 Sep; 8(36):60358-60367. PubMed ID: 28947976 [TBL] [Abstract][Full Text] [Related]
18. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis. Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y PeerJ; 2019; 7():e7408. PubMed ID: 31392101 [TBL] [Abstract][Full Text] [Related]
19. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056 [TBL] [Abstract][Full Text] [Related]
20. Identification of key candidate genes and biological pathways in bladder cancer. Gao X; Chen Y; Chen M; Wang S; Wen X; Zhang S PeerJ; 2018; 6():e6036. PubMed ID: 30533316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]